CAS: 1062149-33-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Enavatuzumab REF: TM-T76865CAS: 1062149-33-0 | >95% | 235.00 €~1,941.00 € | Wed 30 Apr 25 |
 | Enavatuzumab REF: 3D-CLA1263CAS: 1062149-33-0 | - - - | To inquire | Mon 12 May 25 |
Enavatuzumab
CAS:1062149-33-0
Enavatuzumab (PDL192) is a humanized monoclonal antibody targeting TWEAK receptor with anti-tumor activity.
Purity:
>95%
Color and Shape:
Liquid
Ref: TM-T76865
| 1mg | 235.00 € | ||
| 5mg | 629.00 € | ||
| 10mg | 1,005.00 € | ||
| 25mg | 1,488.00 € | ||
| 50mg | 1,941.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
Ref: 3D-CLA1263
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 12 May 2025
